Future investigations should minimize bias through well-defined cohorts, leading to robust exploration of hormone receptor profiles in adenomyosis lesions to unveil therapeutic targets and deepen our understanding of adenomyosis pathogenesis. Here, NR4A1 is linked to adenomyosis.